Senseonics Holdings (SENS) Income from Continuing Operations (2015 - 2026)
Senseonics Holdings (SENS) reported Income from Continuing Operations of 32296000.0 for Q1 2026, down 126.77% year-over-year from 120660973.77 in Q1 2025, and down 55.14% quarter-over-quarter from 20817000.0 in Q4 2025.
Senseonics Holdings (SENS) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Income from Continuing Operations data on file, last reported at 32296000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 32296000.0, down 126.77% year-over-year; the trailing twelve-month figure through Mar 2026 was 87144000.0 (down 17.57% YoY), and the FY2025 annual result was 69090000.0, up 12.3% from the prior year.
- Income from Continuing Operations slipped to 32296000.0 in Q1 2026 per SENS's latest filing, from 20817000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 14242000.0 in Q1 2025 and troughed at 32296000.0 in Q1 2026.
- A 5-year average of 20412823.53 and a median of 20388000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2026: Income from Continuing Operations surged 32.66% in 2023, then plunged 126.77% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 25607000.0 in 2022, then surged by 32.66% to 17243000.0 in 2023, then rose by 9.97% to 15524000.0 in 2024, then slumped by 34.1% to 20817000.0 in 2025, then sank by 55.14% to 32296000.0 in 2026.
- Business Quant data shows SENS's Income from Continuing Operations at 32296000.0 in Q1 2026, 20817000.0 in Q4 2025, and 19536000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | -32.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.30 Mn |
| Dec 31, 2025 | -20.82 Mn |
| Sep 30, 2025 | -19.54 Mn |
| Jun 30, 2025 | -14.50 Mn |
| Mar 31, 2025 | -14.24 Mn |
| Dec 31, 2024 | -15.52 Mn |
| Sep 30, 2024 | -23.97 Mn |
| Jun 30, 2024 | -20.39 Mn |
| Mar 31, 2024 | -18.90 Mn |
| Dec 31, 2023 | -17.24 Mn |
| Sep 30, 2023 | -19.99 Mn |
| Jun 30, 2023 | -20.87 Mn |
| Mar 31, 2023 | -23.25 Mn |
| Dec 31, 2022 | -25.61 Mn |
| Sep 30, 2022 | -21.83 Mn |
| Jun 30, 2022 | -21.31 Mn |
| Mar 31, 2022 | -16.77 Mn |
| Dec 31, 2021 | -18.83 Mn |
| Sep 30, 2021 | -19.79 Mn |
| Jun 30, 2021 | -19.68 Mn |